Urinary tract infections in kidney transplant recipients

Role of gender, urologic abnormalities, and antimicrobial prophylaxis

Ella J. Ariza-Heredia, Elena N. Beam, Timothy G. Lesnick, Walter K Kremers, Fernando G Cosio, Raymund R Razonable

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background: Urinary tract infections (UTI), the most common infectious complications after kidney transplantation, are associated with poor allograft survival. Identifying its predisposing factors is therefore remarkably important in order to optimize prevention strategies. Material/Methods: A retrospective study was performed in a cohort of patients who received kidney transplantation between June 2007 and June 2009. Factors associated with development of UTI were assessed. Results: The population consisted of 301 patients, with majority receiving allograft from living donors (85%). A total of 101 patients (34%) developed at least one episode of UTI, and 25% of the episodes occurred during the first year after transplantation. Risk factors associated with increased risk of UTI were female gender, recurrent UTI prior to transplant, and presence of urological abnormalities. Trimethoprimsulfamethoxazole (TMP-SMZ) use was associated with a lower risk of UTI, including a lower risk of recurrent UTI. Conclusions: In this cohort of predominantly living donor kidney transplant recipients, we report a high incidence of UTI, despite our practice of early ureteral and Foley catheter removal. Female gender and prior recurrent UTI or urological abnormalities were predisposing factors, while TMP-SMZ use had a protective role. These clinical relevant findings should guide clinicians in optimizing prevention strategies against UTI in kidney transplant recipients.

Original languageEnglish (US)
Pages (from-to)195-204
Number of pages10
JournalAnnals of Transplantation
Volume18
Issue number1
DOIs
StatePublished - 2013

Fingerprint

Urinary Tract Infections
Kidney
Thymidine Monophosphate
Living Donors
Causality
Kidney Transplantation
Allografts
Transplant Recipients
Urinary Catheters
Retrospective Studies
Transplantation
Transplants
Incidence

Keywords

  • Living donor
  • Renal transplantation
  • Risk factors
  • TMP/SMZ
  • Urologic abnormalities

ASJC Scopus subject areas

  • Transplantation

Cite this

Urinary tract infections in kidney transplant recipients : Role of gender, urologic abnormalities, and antimicrobial prophylaxis. / Ariza-Heredia, Ella J.; Beam, Elena N.; Lesnick, Timothy G.; Kremers, Walter K; Cosio, Fernando G; Razonable, Raymund R.

In: Annals of Transplantation, Vol. 18, No. 1, 2013, p. 195-204.

Research output: Contribution to journalArticle

@article{32a97d62756542ce9544d6a78821436d,
title = "Urinary tract infections in kidney transplant recipients: Role of gender, urologic abnormalities, and antimicrobial prophylaxis",
abstract = "Background: Urinary tract infections (UTI), the most common infectious complications after kidney transplantation, are associated with poor allograft survival. Identifying its predisposing factors is therefore remarkably important in order to optimize prevention strategies. Material/Methods: A retrospective study was performed in a cohort of patients who received kidney transplantation between June 2007 and June 2009. Factors associated with development of UTI were assessed. Results: The population consisted of 301 patients, with majority receiving allograft from living donors (85{\%}). A total of 101 patients (34{\%}) developed at least one episode of UTI, and 25{\%} of the episodes occurred during the first year after transplantation. Risk factors associated with increased risk of UTI were female gender, recurrent UTI prior to transplant, and presence of urological abnormalities. Trimethoprimsulfamethoxazole (TMP-SMZ) use was associated with a lower risk of UTI, including a lower risk of recurrent UTI. Conclusions: In this cohort of predominantly living donor kidney transplant recipients, we report a high incidence of UTI, despite our practice of early ureteral and Foley catheter removal. Female gender and prior recurrent UTI or urological abnormalities were predisposing factors, while TMP-SMZ use had a protective role. These clinical relevant findings should guide clinicians in optimizing prevention strategies against UTI in kidney transplant recipients.",
keywords = "Living donor, Renal transplantation, Risk factors, TMP/SMZ, Urologic abnormalities",
author = "Ariza-Heredia, {Ella J.} and Beam, {Elena N.} and Lesnick, {Timothy G.} and Kremers, {Walter K} and Cosio, {Fernando G} and Razonable, {Raymund R}",
year = "2013",
doi = "10.12659/AOT.883901",
language = "English (US)",
volume = "18",
pages = "195--204",
journal = "Annals of Transplantation",
issn = "1425-9524",
publisher = "International Scientific Information, Inc.",
number = "1",

}

TY - JOUR

T1 - Urinary tract infections in kidney transplant recipients

T2 - Role of gender, urologic abnormalities, and antimicrobial prophylaxis

AU - Ariza-Heredia, Ella J.

AU - Beam, Elena N.

AU - Lesnick, Timothy G.

AU - Kremers, Walter K

AU - Cosio, Fernando G

AU - Razonable, Raymund R

PY - 2013

Y1 - 2013

N2 - Background: Urinary tract infections (UTI), the most common infectious complications after kidney transplantation, are associated with poor allograft survival. Identifying its predisposing factors is therefore remarkably important in order to optimize prevention strategies. Material/Methods: A retrospective study was performed in a cohort of patients who received kidney transplantation between June 2007 and June 2009. Factors associated with development of UTI were assessed. Results: The population consisted of 301 patients, with majority receiving allograft from living donors (85%). A total of 101 patients (34%) developed at least one episode of UTI, and 25% of the episodes occurred during the first year after transplantation. Risk factors associated with increased risk of UTI were female gender, recurrent UTI prior to transplant, and presence of urological abnormalities. Trimethoprimsulfamethoxazole (TMP-SMZ) use was associated with a lower risk of UTI, including a lower risk of recurrent UTI. Conclusions: In this cohort of predominantly living donor kidney transplant recipients, we report a high incidence of UTI, despite our practice of early ureteral and Foley catheter removal. Female gender and prior recurrent UTI or urological abnormalities were predisposing factors, while TMP-SMZ use had a protective role. These clinical relevant findings should guide clinicians in optimizing prevention strategies against UTI in kidney transplant recipients.

AB - Background: Urinary tract infections (UTI), the most common infectious complications after kidney transplantation, are associated with poor allograft survival. Identifying its predisposing factors is therefore remarkably important in order to optimize prevention strategies. Material/Methods: A retrospective study was performed in a cohort of patients who received kidney transplantation between June 2007 and June 2009. Factors associated with development of UTI were assessed. Results: The population consisted of 301 patients, with majority receiving allograft from living donors (85%). A total of 101 patients (34%) developed at least one episode of UTI, and 25% of the episodes occurred during the first year after transplantation. Risk factors associated with increased risk of UTI were female gender, recurrent UTI prior to transplant, and presence of urological abnormalities. Trimethoprimsulfamethoxazole (TMP-SMZ) use was associated with a lower risk of UTI, including a lower risk of recurrent UTI. Conclusions: In this cohort of predominantly living donor kidney transplant recipients, we report a high incidence of UTI, despite our practice of early ureteral and Foley catheter removal. Female gender and prior recurrent UTI or urological abnormalities were predisposing factors, while TMP-SMZ use had a protective role. These clinical relevant findings should guide clinicians in optimizing prevention strategies against UTI in kidney transplant recipients.

KW - Living donor

KW - Renal transplantation

KW - Risk factors

KW - TMP/SMZ

KW - Urologic abnormalities

UR - http://www.scopus.com/inward/record.url?scp=84887231439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887231439&partnerID=8YFLogxK

U2 - 10.12659/AOT.883901

DO - 10.12659/AOT.883901

M3 - Article

VL - 18

SP - 195

EP - 204

JO - Annals of Transplantation

JF - Annals of Transplantation

SN - 1425-9524

IS - 1

ER -